By Siddhi Mahatole and Puyaan Singh (Reuters) -INmune Bio said on Monday its experimental Alzheimer's drug failed to improve ...

Dementia poses a major health challenge with no safe, affordable treatments to slow its progression. Researchers at Lawson ...

A 12-month clinical trial investigated whether a cough medicine used in Europe called Ambroxol can slow dementia in people with Parkinson’s.

Dementia rates vary dramatically across U.S. regions in ways that can't be explained by age, education, or health conditions.

The Alzheimer’s Foundation of America (AFA) is offering some tips for families to create a dementia-friendly Fourth of July.

Over 7 million Americans are living with Alzheimer’s, which is a brain disorder that impacts a person's memory. Five years ...

Researchers have discovered that newborns have high levels of the tau protein, which is elevated in older people with ...

Scientists have uncovered a surprising sugar-related mechanism inside brain cells that could transform how we fight Alzheimer ...

The team used a special type of brain scan called tau PET, which tracks a protein known as tau that builds up in the brain ...

Researchers have developed a blood test that detects Alzheimer's biomarkers at single-molecule levels, enabling earlier, ...

Digging into a prespecified analysis for the mid-stage study, INmune Bio identified some clinical and biological benefits of ...

Shares of INmune Bio ( NASDAQ: INMB) dropped on Monday after the company did not achieve the main goal in a mid-stage trial ...